{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,5]],"date-time":"2025-01-05T05:14:52Z","timestamp":1736054092537,"version":"3.32.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T00:00:00Z","timestamp":1735948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cardiothorac Surg"],"DOI":"10.1186\/s13019-024-03278-6","type":"journal-article","created":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T07:51:20Z","timestamp":1735977080000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of the effect of initial hemostasis resuscitation with recombinant human coagulation factor VII a on the treatment of postoperative hemorrhage in cardiac surgery"],"prefix":"10.1186","volume":"20","author":[{"given":"Yan","family":"Yu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maomao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuran","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,4]]},"reference":[{"issue":"3","key":"3278_CR1","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.transproceed.2006.01.047","volume":"38","author":"M Marietta","year":"2006","unstructured":"Marietta M, Facchini L, Pedrazzi P, Busani S, Torelli G. Pathophysiology of bleeding in surgery. Transpl Proc. 2006;38(3):812\u20134.","journal-title":"Transpl Proc"},{"issue":"10","key":"3278_CR2","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1111\/j.1537-2995.2004.04144.x","volume":"44","author":"DNW Keyvan Karkouti","year":"2004","unstructured":"Keyvan Karkouti DNW, Terrence M, Yau W, Scott Beattie E, Abdelnaem SA, McCluskey M, Ghannam. Eric Yeo, George Djaiani, Jacek Karski: the independent association of massive blood loss with mortality in cardiac surgery. Transfusion. Oct; 2004;44(10):1453\u201362.","journal-title":"Transfusion"},{"issue":"2","key":"3278_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000338034","volume":"39","author":"P Lau","year":"2012","unstructured":"Lau P, Ong V, Tan WT, Koh PL, Hartman M. Use of activated recombinant factor VII in severe bleeding - evidence for Efficacy and Safety in Trauma, Postpartum Hemorrhage, Cardiac surgery, and gastrointestinal bleeding. Transfus Med Hemother. 2012;39(2):139\u201350.","journal-title":"Transfus Med Hemother"},{"issue":"12","key":"3278_CR4","doi-asserted-by":"publisher","first-page":"4558","DOI":"10.1111\/jocs.16048","volume":"36","author":"K Dustin Hang","year":"2021","unstructured":"Dustin Hang K, Koss CK, Rokkas PS, Pagel. Recombinant activated factor VII for hemostasis in patients undergoing complex ascending aortic surgery: a single-center, single-surgeon retrospective analysis. J Card Surg. Dec; 2021;36(12):4558\u201363.","journal-title":"J Card Surg"},{"issue":"2","key":"3278_CR5","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1177\/0885066620984443","volume":"37","author":"A Katz","year":"2022","unstructured":"Katz A, Ahuja T, Arnouk S, Lewis TC, Marsh K, Papadopoulos J, Merchan C. A comparison of Prothrombin Complex Concentrate and recombinant activated factor VII for the management of bleeding with cardiac surgery. J Intensive Care Med. 2022;37(2):231\u20139.","journal-title":"J Intensive Care Med"},{"issue":"2","key":"3278_CR6","first-page":"241","volume":"122","author":"Management","year":"2015","unstructured":"Management, ASoATFoPB. Practice guidelines for perioperative blood management: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Management. Anesthesiology 2015. 2015;122(2):241\u201375.","journal-title":"Anesthesiology 2015"},{"issue":"12","key":"3278_CR7","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1111\/j.1365-2044.2005.04376.x","volume":"60","author":"IJ Welsby","year":"2005","unstructured":"Welsby IJ, Monroe DM, Lawson JH, Hoffmann M. Recombinant activated factor VII and the anaesthetist. Anaesthesia. 2005;60(12):1203\u201312.","journal-title":"Anaesthesia"},{"key":"3278_CR8","doi-asserted-by":"crossref","unstructured":"S\u00f8ren Brandsborg BS. Lone Hvitfeldt Poulsen, J\u00f8rgen Ingerslev: Recombinant activated factor VIIa in uncontrolled bleeding: a haemostasis laboratory study in non-haemophilia patients. Blood Coagul Fibrinolysis 2006, 2006;17(4):241-9.","DOI":"10.1097\/01.mbc.0000224842.25592.8a"},{"issue":"6","key":"3278_CR9","doi-asserted-by":"publisher","first-page":"H2680","DOI":"10.1152\/ajpheart.00425.2005","volume":"289","author":"N Lindenblatt","year":"2005","unstructured":"Lindenblatt N, Menger MD, Klar E, Vollmar B. Sustained hypothermia accelerates microvascular thrombus formation in mice. Am J Physiol Heart Circ Physiol. Dec; 2005;289(6):H2680\u20137.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"3278_CR10","doi-asserted-by":"crossref","unstructured":"Van Sven K, Stevens. Abraham Emanuel Marcus, Marcus Lanc\u00e9: Hypothermia: effects on platelet function and hemostasis. Thromb J 2014 Dec 9;12(1):31.","DOI":"10.1186\/s12959-014-0031-z"},{"issue":"Suppl 1","key":"3278_CR11","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1111\/j.1538-7836.2009.03412.x","volume":"7","author":"G Despotis","year":"2009","unstructured":"Despotis G, Avidan M, Eby C. Prediction and management of bleeding in cardiac surgery. J Thromb Haemost. 2009;7(Suppl 1):111\u20137.","journal-title":"J Thromb Haemost"},{"issue":"5","key":"3278_CR12","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1213\/ANE.0000000000004355","volume":"129","author":"J Raphael","year":"2019","unstructured":"Raphael J, Mazer CD, Subramani S, Schroeder A, Abdalla M, Ferreira R, Roman PE, Patel N, Welsby I, Greilich PE, et al. Society of Cardiovascular Anesthesiologists Clinical Practice Improvement Advisory for Management of Perioperative Bleeding and hemostasis in cardiac surgery patients. Anesth Analg. 2019;129(5):1209\u201321.","journal-title":"Anesth Analg"},{"issue":"8","key":"3278_CR13","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s12630-013-9937-3","volume":"60","author":"A Turan","year":"2013","unstructured":"Turan A, Yang D, Bonilla A, Shiba A, Sessler DI, Saager L, Kurz A. Morbidity and mortality after massive transfusion in patients undergoing non-cardiac surgery. Can J Anaesth. 2013;60(8):761\u201370.","journal-title":"Can J Anaesth"},{"issue":"1","key":"3278_CR14","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.athoracsur.2016.01.004","volume":"102","author":"J Brase","year":"2016","unstructured":"Brase J, Finger B, He J, Wirtz K, Stun L, McMillen R, Flynn B. Analysis of outcomes using low-dose and Early Administration of Recombinant Activated Factor VII in cardiac surgery. Ann Thorac Surg. 2016;102(1):35\u201340.","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"3278_CR15","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/bja\/aei244","volume":"95","author":"P Diprose","year":"2005","unstructured":"Diprose P, Herbertson MJ, O\u2019Shaughnessy D, Gill RS. Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: randomized double-blind placebo-controlled pilot study. Br J Anaesth. 2005;95(5):596\u2013602.","journal-title":"Br J Anaesth"},{"issue":"10","key":"3278_CR16","doi-asserted-by":"publisher","first-page":"2241","DOI":"10.1097\/01.CCM.0000181527.47749.57","volume":"33","author":"C von Heymann","year":"2005","unstructured":"von Heymann C, Redlich U, Jain U, Kastrup M, Schroeder T, Sander M, Grosse J, Ziemer S, Koscielny J, Konertz WF, et al. Recombinant activated factor VII for refractory bleeding after cardiac surgery\u2013a retrospective analysis of safety and efficacy. Crit Care Med. 2005;33(10):2241\u20136.","journal-title":"Crit Care Med"},{"key":"3278_CR17","doi-asserted-by":"crossref","unstructured":"Henry Ekert CB, Eyers R, Cochrane A, Henning R. Elective administration in infants of low-dose recombinant activated factor VII (rFVIIa) in cardiopulmonary bypass surgery for congenital heart disease does not shorten time to chest closure or reduce blood loss and need for transfusions: a randomized, double-blind, parallel group, placebo-controlled study of rFVIIa and standard haemostatic replacement therapy versus standard haemostatic replacement therapy. Blood Coagul Fibrinolysis 2006, 2006;17(5):389\u2009\u2013\u200995.","DOI":"10.1097\/01.mbc.0000233369.03358.c1"},{"key":"3278_CR18","doi-asserted-by":"crossref","unstructured":"Feih JT, Juul JJ JR, Baumann Kreuziger GR, Pagel LM, Tawil PS. Adequacy of hemostatic resuscitation improves therapeutic efficacy of recombinant activated factor VII and reduces reexploration rate for bleeding in postoperative cardiac surgery patients with refractory hemorrhage. Ann Card Anaesth. 2019;22(4):388\u201393.","DOI":"10.4103\/aca.ACA_108_18"},{"key":"3278_CR19","doi-asserted-by":"publisher","first-page":"100733","DOI":"10.1016\/j.blre.2020.100733","volume":"46","author":"Y Sang","year":"2021","unstructured":"Sang Y, Roest M, de Laat B, de Groot PG, Huskens D. Interplay between platelets and coagulation. Blood Rev. 2021;46:100733.","journal-title":"Blood Rev"},{"issue":"4","key":"3278_CR20","doi-asserted-by":"publisher","first-page":"2965","DOI":"10.1074\/jbc.M110070200","volume":"277","author":"WS Nesbitt","year":"2002","unstructured":"Nesbitt WS, Kulkarni S, Giuliano S, Goncalves I, Dopheide SM, Yap CL, Harper IS, Salem HH, Jackson SP. Distinct glycoprotein Ib\/V\/IX and integrin alpha IIbbeta 3-dependent calcium signals cooperatively regulate platelet adhesion under flow. J Biol Chem. 2002;277(4):2965\u201372.","journal-title":"J Biol Chem"},{"issue":"4","key":"3278_CR21","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/nrm2871","volume":"11","author":"SJ Shattil","year":"2010","unstructured":"Shattil SJ, Kim C, Ginsberg MH. The final steps of integrin activation: the end game. Nat Rev Mol Cell Biol. 2010;11(4):288\u2013300.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"3","key":"3278_CR22","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/0268-960X(95)90020-9","volume":"9","author":"HD D Blockmans","year":"1995","unstructured":"D Blockmans HD, Vermylen J. Platelet activation. Blood Rev. Sep; 1995;9(3):143\u201356.","journal-title":"Blood Rev"},{"issue":"12","key":"3278_CR23","doi-asserted-by":"publisher","first-page":"3385","DOI":"10.1172\/JCI26869","volume":"115","author":"LF Brass","year":"2005","unstructured":"Brass LF, Zhu L, Stalker TJ. Minding the gaps to promote thrombus growth and stability. J Clin Invest. 2005;115(12):3385\u201392.","journal-title":"J Clin Invest"},{"key":"3278_CR24","doi-asserted-by":"crossref","unstructured":"Cees Weeterings PG, de Groot J, Adelmeijer T, Lisman. The glycoprotein Ib-IX-V complex contributes to tissue factor-independent thrombin generation by recombinant factor VIIa on the activated platelet surface. Blood. 2008, Oct 15;112(8):3227-33.","DOI":"10.1182\/blood-2008-02-139113"},{"issue":"9","key":"3278_CR25","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1111\/jth.14165","volume":"16","author":"AM Fager","year":"2018","unstructured":"Fager AM, Machlus KR, Ezban M, Hoffman M. Human platelets express endothelial protein C receptor, which can be utilized to enhance localization of factor VIIa activity. J Thromb Haemost. Sep; 2018;16(9):1817\u201329.","journal-title":"J Thromb Haemost"},{"issue":"4","key":"3278_CR26","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.blre.2014.12.004","volume":"29","author":"PG Ton Lisman","year":"2015","unstructured":"Ton Lisman PG, de Groot. The role of cell surfaces and cellular receptors in the mode of action of recombinant factor VIIa. Blood Rev. Jul; 2015;29(4):223\u20139.","journal-title":"Blood Rev"},{"issue":"7","key":"3278_CR27","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1080\/09537104.2018.1535706","volume":"30","author":"M Ranucci","year":"2019","unstructured":"Ranucci M, Pistuddi V, Di Dedda U, Menicanti L, De Vincentiis C, Baryshnikova E. Platelet function after cardiac surgery and its association with severe postoperative bleeding: the PLATFORM study. Platelets. 2019;30(7):908\u201314.","journal-title":"Platelets"},{"issue":"1","key":"3278_CR28","first-page":"137","volume":"102","author":"M Karlsson","year":"2009","unstructured":"Karlsson M, Ternstrom L, Hyllner M, Baghaei F, Flinck A, Skrtic S, Jeppsson A. Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery. A prospective randomised pilot study. Thromb Haemost. 2009;102(1):137\u201344.","journal-title":"Thromb Haemost"},{"issue":"21\u201322","key":"3278_CR29","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1111\/jocn.12936","volume":"24","author":"CT Lopes","year":"2015","unstructured":"Lopes CT, Dos Santos TR, Brunori EH, Moorhead SA, Lopes Jde L, Barros AL. Excessive bleeding predictors after cardiac surgery in adults: integrative review. J Clin Nurs. 2015;24(21\u201322):3046\u201362.","journal-title":"J Clin Nurs"},{"issue":"4","key":"3278_CR30","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.thromres.2014.05.023","volume":"134","author":"C Shams Hakimi","year":"2014","unstructured":"Shams Hakimi C, Fagerberg Blixter I, Hansson EC, Hesse C, Wallen H, Jeppsson A. Effects of fibrinogen and platelet supplementation on clot formation and platelet aggregation in blood samples from cardiac surgery patients. Thromb Res. 2014;134(4):895\u2013900.","journal-title":"Thromb Res"}],"container-title":["Journal of Cardiothoracic Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-03278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13019-024-03278-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13019-024-03278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,4]],"date-time":"2025-01-04T08:03:22Z","timestamp":1735977802000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiothoracicsurgery.biomedcentral.com\/articles\/10.1186\/s13019-024-03278-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,4]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3278"],"URL":"https:\/\/doi.org\/10.1186\/s13019-024-03278-6","relation":{},"ISSN":["1749-8090"],"issn-type":[{"value":"1749-8090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,4]]},"assertion":[{"value":"30 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study has been reviewed by the Ethics Committee of Beijing Anzhen Hospital, Capital Medical University (IRB2023205X), and was conducted under the supervision of the Ethics Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13"}}